Navigation Links
Prostate Cancer Patients in US and Europe Receive Treatments Using Enhanced Seed Prostate Brachytherapy Software
Date:3/31/2009

Varian's VariSeed(TM) 8.0 Offers Advantages in Simplifying Dose Planning and Identifying Seed Positions, according to Clinicians

CHARLOTTESVILLE, Va., March 31 /PRNewswire-FirstCall/ -- Prostate cancer patients have begun receiving brachytherapy using new treatment planning software that enables improvements in the precision and speed of the treatment process. VariSeed(TM) 8.0 from Varian Medical Systems (NYSE: VAR) is an updated version of the company's market-leading treatment planning software for Low Dose Rate (LDR) brachytherapy in which radiation doses are delivered by implanting seeds within the prostate.

With VariSeed 8.0, doctors can use the new software to target individual sectors of the prostate based on biopsy results, according to Rebecca Claydon, software product manager with Varian's Brachytherapy business unit. "We have also speeded up the planning process considerably with an improved SeedFinder(TM) algorithm," Claydon said. "The use of a 3-D Digital Reconstructed Radiograph (DRR) generated from a CT allows doctors to more easily see and interactively add or remove proposed seed locations from the treatment plan."

According to Dr. William Bice, recently at the University of Texas Health Science Center at San Antonio but now practicing at The London Clinic in England, the main benefit of VariSeed 8.0 over previous versions of the product is its ability to perform sector analysis. "The new version of VariSeed features some significant improvements in several different areas, particularly the ability to target regions using sector analysis," said Dr. Bice. "It is now easier to verify seed locations following source localization and reconstruction using the projection display in VariSeed 8.0."

At Kuopio University Hospital in Finland, brachytherapy physicist Jan-Erik Palmg
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Wayne State University Scientists ID New Biomarker for Prostate Cancer
2. American Urological Association Statement in Support of Prostate-Specific Antigen Testing
3. A new approach to prostate cancer detection
4. Scientists ID New Biomarker for Prostate Cancer
5. Omega-3 Fatty Acids Guard Against Advanced Prostate Cancer
6. Omega-3 fatty acids reduce risk of advanced prostate cancer
7. AUDIO from Medialink and Mens Health Network: Important Decision Regarding Prostate Cancer
8. SPCG-4 trial: Update on watchful waiting versus radical prostatectomy
9. Castrate resistant prostate cancer: New therapeutic approaches
10. Free Community Seminar to Review Treatment Options for Enlarged Prostate
11. US trial shows no early mortality benefit from annual prostate cancer screening
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Medical Debt Sending Many Over Financial Brink 2Health News:Medical Debt Sending Many Over Financial Brink 3Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 2Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 3Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 4Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 5Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 6Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 7Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 8Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 9Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 10Health News:Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 11Health News:Pharmasset to Webcast an Investor Event from the AASLD Meeting 2Health News:Pharmasset to Webcast an Investor Event from the AASLD Meeting 3Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 2Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 3Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 4Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 5Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 6Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 7Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 8Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 9Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 10Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 11Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 12Health News:LCA-Vision Reports Third Quarter 2008 Financial Results 13Health News:Battelle to Perform Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process 2Health News:Battelle to Perform Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process 3Health News:Galenea and Organix Announce Exclusive License Agreement for 5-HT2C Agonists for the Treatment of Obesity 2Health News:Galenea and Organix Announce Exclusive License Agreement for 5-HT2C Agonists for the Treatment of Obesity 3
Breaking Medicine Technology:Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 1DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 2DIA FDA PhRMA to Host Progression Free Survival Oncology Workshop 55448 3Slogan Contest Educates Young Baseball and Softball Players About the Dangers of Tobacco Use 55445 1Slogan Contest Educates Young Baseball and Softball Players About the Dangers of Tobacco Use 55445 2UT Southwestern Responds to VA Announcement 55442 1